tiprankstipranks
Immutep Increases Director’s Stake with New Performance Rights
Company Announcements

Immutep Increases Director’s Stake with New Performance Rights

Immutep Ltd (AU:IMM) has released an update.

Pick the best stocks and maximize your portfolio:

Immutep Ltd has announced a change in the interest of its director Dr. Frederic Triebel, with an issuance of 2.7 million performance rights, doubling his holdings of these rights under the company’s Executive Incentive Plan. This change, approved by shareholders, reflects confidence in the company’s future performance and strategic direction. Investors in Immutep might see this as a positive signal for the company’s growth trajectory.

For further insights into AU:IMM stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyImmutep announces results from Cohort B of TACTI-003 trial
TipRanks Australian Auto-Generated NewsdeskImmutep’s Promising Trial Results in Cancer Therapy
TheFlyImmutep announces initiation of TACTI-004 Phase III trial
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App